Anxiety in the Pediatric Medical Setting

Child and Adolescent Psychiatric Clinics of North America

Volumn 21, Issue 3, 2012, Pages 643-653

  Gandhi, Bela ^a   Cheek, Shannon ^a   Campo, John V ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Anxiety; Chronic disease; Differential diagnosis; Gastrointestinal diseases; Somatoform disorders

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; DEXTROMETHORPHAN; DULOXETINE; MIRTAZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; VENLAFAXINE;

ADJUVANT THERAPY; AGE; ANXIETY DISORDER; ASTHMA; CHRONIC DISEASE; COGNITIVE THERAPY; COMORBIDITY; COPING CAT PROGRAM; DIET; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; EPILEPSY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOSOMATIC DISORDER; PSYCHOTHERAPY; QT PROLONGATION; REVIEW; RISK FACTOR; SIDE EFFECT; THROMBOCYTE DISORDER; TREATMENT FOR ANXIETY AND PHYSICAL SYMPTOMS PROGRAM; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; ANXIETY DISORDERS; BENZODIAZEPINES; CHILD; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS; SOMATOFORM DISORDERS;

EID: 84863865917     PISSN: 10564993     EISSN: 15580490     Source Type: Journal    
DOI: 10.1016/j.chc.2012.05.013     Document Type: Review

References (57)

1. Pine D.S., Cohen P., Gurley D., et al. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998, 55:56-64.
2. Woodward L.J., Fergusson D.M. Life course outcomes of young people with anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry 2001, 40(9):1086-1093.
3. Klein R.G. Anxiety disorders. J Child Psychol Psychiatry 2009, 50(1-2):153-162.
4. Gortmaker S.L., Walker D.K., Weitzman M., et al. Chronic conditions, socioeconomic risks, and behavioral problems in children and adolescents. Pediatrics 1990, 85:267-276.
5. Pao M., Bosk A. Anxiety in medically ill children/adolescents. Depress Anxiety 2011, 28:40-49.
6. Campo J.V. Medical issues in the care of child and adolescent inpatients. Handbook of behavior therapy in the psychiatric setting 1993, 373-406. Plenum Publishing Corporation, New York. A. Bellack, M. Hersen (Eds.).
7. Campo J.V. Annual research review: functional somatic symptoms and associated anxiety and depression-developmental psychopathology in pediatric practice. J Child Psychol Psychiatry 2012, 53(5):575-592.
8. LeDoux J.E. The emotional brain 1996, Simon & Schuster, New York.
9. Ramsawh H., Chavira D., Stein M. The burden of anxiety disorders in pediatric medical settings: prevalence, phenomenology and a research agenda. Arch Pediatr Adolesc Med 2010, 164:965-972.
10. Weiner H., Fawzy F.I. An integrative model of health, disease, and illness. Psychosomatic medicine: theory, physiology, and practice 1989, vol. 1:9-44. International University Press, Madison (CT). S. Cheren (Ed.).
11. Schiffer R.B., Klein R.F., Sider R.C. The medical evaluation of psychiatric patients 1998, Plenum Medical Book Co., New York.
12. Seifert S.M., Schaechter J.L., Hershorin E.R., et al. Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 2011, 127(3):511-528.
13. Thomas H. Psychiatric symptoms in cannabis users. Br J Psychiatry 1993, 163:141-149.
14. Drugs that may cause psychiatric symptoms. Med Lett Drugs Ther 2008, 1301:100.
15. Birmes P., Coppin D., Schmitt L., et al. Serotonin syndrome: a brief review. CMAJ 2003, 168(11):1439-1442.
16. Millward L.M., Kelly P., King A., et al. Anxiety and depression in the acute porphyrias. J Inherit Metab Dis 2005, 28(6):1099-1107.
17. O'Donovan A., Tomiyama A.J., Lin J., et al. Stress appraisals and cellular aging: a key role for anticipatory threat in the relationship between psychological stress and telomere length. Brain Behav Immun 2012, 26(4):573-579.
18. Player M.S., Peterson L.E. Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med 2011, 41(4):365-377.
19. Roy-Byrne P.P., Davidson K.W., Kessler R.C., et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008, 30(3):208-225.
20. Danzer C., Swendsen J., Maurice-Tison S., et al. Anxiety and depression in juvenile diabetes: a critical review. Clin Psychol Rev 2003, 23:787-800.
21. Chavira D.A., Garland A.F., Daley S., et al. The impact of medical comorbidity on mental health and functional health outcomes among children with anxiety disorders. J Dev Behav Pediatr 2008, 29(5):394-402.
22. Katon W.J., Richardson L., Lozano P., et al. The relationship of asthma and anxiety disorders. Psychosom Med 2004, 66(3):349-355.
23. Katon W., Lozano P., Russo J., et al. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolesc Health 2007, 41(5):455-463.
24. Richardson L.P., Russo J.E., Lozano P., et al. The effect of comorbid anxiety and depressive disorders on health care utilization and costs among adolescents with asthma. Gen Hosp Psychiatry 2008, 30(5):398-406.
25. McCauley E., Katon W., Russo J., et al. Impact of anxiety and depression on functional impairment in adolescents with asthma. Gen Hosp Psychiatry 2007, 29(3):214-222.
26. Bush T., Richardson L., Katon W., et al. Anxiety and depressive disorders are associated with smoking in adolescents with asthma. J Adolesc Health 2007, 40(5):425-432.
27. Gavin L.A., Wamboldt M., Brugman S., et al. Psychological and family characteristics of adolescents with vocal cord dysfunction. J Asthma 1998, 35:409-417.
28. Ekinci O., Titus J.B., Rodopman A.A., et al. Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment. Epilepsy Behav 2009, 14(1):8-18.
29. Caplan R., Siddarth P., Gurbani S., et al. Depression and anxiety disorders in pediatric epilepsy. Epilepsia 2005, 46:720-730.
30. Jones J.E., Watson R., Sheth R., et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol 2007, 49:493-497.
31. Oguz A., Kurul S., Direk E. Relationship of epilepsy-related factors to anxiety and depression scores in epileptic children. J Child Neurol 2002, 17(1):37-40.
32. Mintzer L.L., Stuber M.L., Seacord D., et al. Traumatic stress symptoms in adolescent organ transplant recipients. Pediatrics 2005, 115(6):1640-1644.
33. Stuber M.L., Shemesh E. Post-traumatic stress response to life-threatening illnesses in children and their parents. Child Adolesc Psychiatr Clin N Am 2006, 15(3):597-609.
34. Stuber M.L., Meeske K.A., Krull K.R., et al. Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer. Pediatrics 2010, 125(5):e1124-e1134.
35. Davydow D.S., Richardson L.P., Zatzick D.F., et al. Psychiatric morbidity in pediatric critical illness survivors: a comprehensive review of the literature. Arch Pediatr Adolesc Med 2010, 164(4):377-385.
36. Campo J.V., Bridge J., Ehmann M., et al. Recurrent abdominal pain, anxiety, and depression in primary care. Pediatrics 2004, 113(4):817-824.
37. Egger H., Costello E., Erkanli A., et al. Somatic complaints and psychopathology in children and adolescents: stomachaches, musculoskeletal pains and headaches. J Am Acad Child Adolesc Psychiatry 1999, 38:852-860.
38. Campo J.V., Bridge J., Lucas A., et al. Physical and emotional health of mothers of youth with functional abdominal pain. Arch Pediatr Adolesc Med 2007, 161(2):131-137.
39. Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, American Psychiatric Association, Washington (DC). 4th edition.
40. DeMaso D.R., Martini D.R., Cahen L.A., et al. Practice parameter for the psychiatric assessment and management of physically ill children and adolescents. J. Am. Acad Child Adolesc Psychiatry 2009, 48(2):213-233.
41. Connolly S.D., Bernstein G.A. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J. Am Acad Child Adolesc Psychiatry 2007, 46(2):267-283. Workgroup on Quality Issues.
42. Compton S.N., March J.S., Brent D., et al. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry 2004, 43:930-959.
43. James A., Soler A., Weatehrall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2005, 19. CD004690.
44. Walkup J.T., Albano A.M., Piacentini J., et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008, 359(26):2753-2766.
45. Kendall P.C., Pimentel S. On the physiological symptom constellation in youth with generalized anxiety disorders. J Anxiety Disord 2003, 17:211-221.
46. Sanders M., Shepard R., Cleghorn G., et al. The treatment of recurrent abdominal pain in children: a controlled comparison of cognitive-behavioral family intervention and standard pediatric care. J Consult Clin Psychol 1994, 62:306-314.
47. Warner C.M., Reigada L.C., Fisher P.H., et al. CBT for anxiety and associated somatic complaints in pediatric medical settings: an open pilot study. J Clin Psychol Med Settings 2009, 16:169-177.
48. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001, 344:1279-1285. Research Unit on Pediatric Psychopharmacology Anxiety Study Group.
49. Rynn M., Regan J. Anxiety disorders. Clinical manual of child and adolescent psychopharmacology 2008, 143-188. American Psychiatric Publishing, Inc, Washington (DC). R. Findling (Ed.).
50. Campo J.V. Disorders primarily seen in general medical settings. Clinical manual of child and adolescent psychopharmacology 2008, 375-413. American Psychiatric Publishing, Inc, Washington, DC. R. Findling (Ed.).
51. FDA drug safety communication: abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide) US Food and Drug Administration, Published 2011, Accessed February 23, 2012. http://www.fda.gov/Drugs/DrugSafety/uscm269086.htm.
52. Howland R. A critical evaluation of the cardiac toxicity of citalopram. J Psychosoc Nurs Ment Health Serv 2011, 49:13-16.
53. Campo J.V., Perel J., Lucas A., et al. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study. J Am Acad Child Adolesc Psychiatry 2004, 43(10):1234-1242.
54. Kaminski A., Kamper A., Thaler K. Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents. Cochrane Database Syst Rev 2011, 7. CD008013.
55. Bahar R., Collins B., Steinmetz B., et al. Double-blind placebo controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatrics 2008, 152:685-689.
56. Saps M., Youssef N., Miranda A., et al. Multicenter, randomized placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology 2009, 137:1261-1269.
57. Geller B., Reising D., Leonard H.L., et al. Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999, 38:513-516.